Hypofractionated Radiotherapy with Sequential Anthracycline-based Chemotherapy in Marginally Resectable Soft Tissue Sarcomas: Final Results of a Phase II Clinical Trial

被引：0
|
作者：
Spalek, M. [1 ]
Kosela-Paterczyk, H. [1 ]
Borkowska, A. [1 ]
Wagrodzki, M. [2 ]
Szumera-Cieckiewicz, A. [2 ]
Czarnecka, A. M. [1 ,3 ]
Castaneda-Wysocka, P. [4 ]
Dabrowska-Szewczyk, E. [5 ]
Cieszanowski, A. [4 ]
Rutkowski, P. [1 ]
机构：
[1] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Soft Tissue Bone Sarcoma & Melanoma, Warsaw, Poland
[2] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Pathol, Warsaw, Poland
[3] Polish Acad Sci, Dept Expt Pharmacol, Mossakowski Med Res Ctr, Warsaw, Poland
[4] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Radiol 1, Warsaw, Poland
[5] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Med Phys, Warsaw, Poland
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2020年 / 108卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1031
引用
收藏
页码：S131 / S131
页数：1
相关论文
共 50 条
  • [21] Once-weekly hypofractionated radiotherapy for breast cancer: First results of a phase II clinical trial
    Reboucas, Lievin Matos
    Campos, Conceicao Souza
    D'Amico, Giovanna Melicio
    Lustosa, Alysson Bastos
    Fregnani, Jose Humberto
    BREAST JOURNAL, 2019, 25 (05): : 953 - 957
  • [22] Maintenance treatment with toripalimab and anlotinib after anthracycline-based chemotherapy in patients with advanced soft tissue sarcoma (TORAN): A single-arm, phase 2 trial
    Deng, Yaotiao
    Liu, Jie
    Li, Mei
    Jiang, Yu
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [23] CYCLOPHOSPHAMIDE VERSUS IFOSFAMIDE - FINAL REPORT OF A RANDOMIZED PHASE-II TRIAL IN ADULT SOFT-TISSUE SARCOMAS
    BRAMWELL, VHC
    MOURIDSEN, HT
    SANTORO, A
    BLACKLEDGE, G
    SOMERS, R
    VERWEY, J
    DOMBERNOWSKY, P
    ONSRUD, M
    THOMAS, D
    SYLVESTER, R
    VANOOSTEROM, A
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (03): : 311 - 321
  • [24] A Phase II Trial of Sequential Versus Concurrent Chemotherapy and Radiotherapy Using an Accelerated Hypofractionated Radiation Schedule in Stage III NSCLC
    Maguire, J.
    McMenemin, R.
    O'Rourke, N.
    Peedell, C.
    Snee, M.
    McNee, S.
    Kelly, V.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S558 - S558
  • [25] Sequential dose-dense doxorubicin and ifosfamide for advanced soft tissue sarcomas -: A phase II trial by the Spanish Group for Research on Sarcomas (GEIS)
    Maurel, J
    Fra, J
    López-Pousa, A
    del Muro, XG
    Balañá, C
    Casado, A
    Martín, J
    Martínez-Trufero, J
    de las Peñas, R
    Buesa, JM
    CANCER, 2004, 100 (07) : 1498 - 1506
  • [26] Preoperative Dose-escalated Intensity-modulated Radiotherapy (IMRT) and intraoperative Radiotherapy (IORT) in Patients with retroperitoneal Soft Tissue Sarcoma: Final Results of a Phase I/II clinical Trial
    Seidensaal, Katharina
    Dostal, Matthias
    Kudak, Andreas
    Jaekel, Cornelia
    Liermann, Jakob
    Meixner, Eva
    Mechtersheimer, Gunhild
    Schneider, Martin
    Willis, Franziska
    Debus, Juergen
    STRAHLENTHERAPIE UND ONKOLOGIE, 2023, 199 : S55 - S55
  • [27] The final results of pulmonary resectable metastases of osteosarcoma with antiangiogenic and chemotherapy (PROACH): An open-label, single-arm phase II clinical trial
    Bao, Q.
    Wen, J.
    Zhang, Z.
    Yang, X.
    Shen, Y.
    Zhang, W.
    ANNALS OF ONCOLOGY, 2024, 35 : S1033 - S1033
  • [28] Phase II trial of edatrexate in adult patients with metastatic soft tissue sarcomas, an Eastern Cooperative Oncology Group (ECOG) final report
    Schwartz, C
    Ryan, L
    Nwangwu, J
    Blum, R
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S24 - S24
  • [29] Expression Patterns of TOP2A and SIRT1 Are Predictive of Survival in Patients with High-Risk Soft Tissue Sarcomas Treated with a Neoadjuvant Anthracycline-Based Chemotherapy
    Berclaz, Luc M.
    Altendorf-Hofmann, Annelore
    Duerr, Hans Roland
    Klein, Alexander
    Angele, Martin K.
    Albertsmeier, Markus
    Schmidt-Hegemann, Nina-Sophie
    Di Gioia, Dorit
    Knoesel, Thomas
    Lindner, Lars H.
    CANCERS, 2021, 13 (19)
  • [30] Efficacy of Pazopanib With or Without Gemcitabine in Patients With Anthracycline- and/or Ifosfamide-Refractory Soft Tissue Sarcoma Final Results of the PAPAGEMO Phase 2 Randomized Clinical Trial
    Schmoll, Hans-Joachim
    Lindner, Lars H.
    Reichardt, Peter
    Heissner, Klaus
    Kopp, Hans-Georg
    Kessler, Torsten
    Mayer-Steinacker, Regine
    Ruessel, Joern
    Egerer, Gerlinde
    Crysandt, Martina
    Kasper, Bernd
    Niederwieser, Dietger
    Kunitz, Annegret
    Eigendorff, Ekkehard
    Petersen, Iver
    Steighardt, Joerg
    Cygon, Franziska
    Meinert, Fabian
    Stein, Alexander
    JAMA ONCOLOGY, 2021, 7 (02) : 255 - 262
12345